~~<i id='C3A8D68F6D'><strike id='C3A8D68F6D'><tt id='C3A8D68F6D'><pre id='C3A8D68F6D'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：hotspot 2025-10-01 14:36:22 Page View：4

Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column.

Who we talked to:

Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Why getting cancer drugs just got harder for rural patients
Next article： Supreme Court strikes down use of affirmative action

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

The U.S. needs a new definition of substance use “recovery”

Adobe“WhenIuseaword,”oneof19thcenturyBritishauthorandmathematicianLewisCarroll’scharactersoncesaid,“

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

ALS groups 'won't be played again' by the FDA, drug sponsors

MattScozzariholdshisgirlfriendSabrinaParker'shandduringafriendshipceremonyinJacksonville,N.C.,inNove